Details for New Drug Application (NDA): 009435
✉ Email this page to a colleague
The generic ingredient in NESACAINE-MPF is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
Summary for 009435
Tradename: | NESACAINE-MPF |
Applicant: | Fresenius Kabi Usa |
Ingredient: | chloroprocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 009435
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 009435
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NESACAINE | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435 | NDA | Henry Schein, Inc. | 0404-9926 | 0404-9926-30 | 1 VIAL in 1 BAG (0404-9926-30) / 30 mL in 1 VIAL |
NESACAINE | chloroprocaine hydrochloride | INJECTABLE;INJECTION | 009435 | NDA | Henry Schein, Inc. | 0404-9927 | 0404-9927-30 | 1 VIAL, MULTI-DOSE in 1 BAG (0404-9927-30) / 30 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription